A Pilot Study to Reduce Inappropriate Anticholinergic Prescribing in the Elderly

Completed · Not applicable

Conditions studied: Alzheimer Disease

In brief

This will be an eight-week, prospective, placebo-controlled, randomized trial to evaluate a patient-centered team (pharmacist-physician) intervention to improve medication appropriateness and reduce the use of inappropriate anticholinergic medications in elderly patients enrolled in the Sanders-Brown Alzheimer's Disease Center (ADC) cohort.

Key facts

Study ID

NCT02172612

Run by

Daniela Moga

People needed

50

Starts

2014-09-01

Expected to finish

2015-11-20

Last updated by the study team

2019-03-29

Who can join

Age: 65 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Enrolled at the Sander's Brown Center on Aging Alzheimer Disease Center
• Are 65 years of age or older
• Are taking at least one anticholinergic medication
• No cognitive impairment or mild cognitive impairment

You may not qualify if…

• Are younger than 65 years of age
• Have moderate to severe cognitive impairment
• Live in a long-term care facility

Where it is running

• Sander's BrownCenter on Aging — Lexington, Kentucky, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.